Category: Other Neurological Diseases

James “Jim” G. Scott, Chair, Alliance for Aging Research Board of Directors. Health care in 2019 will no doubt be…

In February 2018, the FDA issued early guidance on clinical trials for early Alzheimer’s disease. The document lays out the FDA’s…

More than 3,500 people from 65 countries will attend World Parkison Conference where they will learn about cutting edge science, clinical research and comprehensive care from some of the most renowned health professionals, researchers, and advocates who are living with Parkinson's. 

We are sharing the following information about two new clinical studies.

Join the WPC for an online webcast to hear about scientific advances since the WPC 2013. 

We wanted to send our sincerest condolences to Martha Stewart and her family on the passing of her sister Laura Kostyra Plimpton. 

My colleagues and I have written previously about the promise and potential of comparative effectiveness research (CER) and the work of the Patient Centered Outcomes Research Institute (PCORI), but also of the challenges in defining the objectives of this research.

As summer drew to a close this year we learned with great sadness of the passing of Dr. Robert Fogel, a brilliant Nobel laureate who in recent years focused on the economics of aging. 

The Patient Centered Outcomes Research Institute (PCORI) held a roundtable today on “implementation and dissemination” of PCOR findings.

The Alliance for Aging Research joined with others in the Alzheimer’s and aging community to call on CMS to provide coverage of Beta Amyloid PET without further evidence (also known as CED, or Coverage with Evidence Development).